- Home
- SPRU vs INKT Comparison
SPRU vs INKT Comparison
Compare SPRU & INKT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SPRU
- INKT
- Stock Information
- Founded
- SPRU 2008
- INKT 2017
- Country
- SPRU United States
- INKT United States
- Employees
- SPRU N/A
- INKT N/A
- Industry
- SPRU Auto Parts:O.E.M.
- INKT Medicinal Chemicals and Botanical Products
- Sector
- SPRU Consumer Discretionary
- INKT Health Care
- Exchange
- SPRU Nasdaq
- INKT Nasdaq
- Market Cap
- SPRU 34.9M
- INKT 28.9M
- IPO Year
- SPRU N/A
- INKT 2021
- Fundamental
- Price
- SPRU $1.69
- INKT $7.28
- Analyst Decision
- SPRU
- INKT Strong Buy
- Analyst Count
- SPRU 0
- INKT 2
- Target Price
- SPRU N/A
- INKT $37.50
- AVG Volume (30 Days)
- SPRU 92.7K
- INKT 14.7K
- Earning Date
- SPRU 08-13-2025
- INKT 08-12-2025
- Dividend Yield
- SPRU N/A
- INKT N/A
- EPS Growth
- SPRU N/A
- INKT N/A
- EPS
- SPRU N/A
- INKT N/A
- Revenue
- SPRU $87,638,000.00
- INKT N/A
- Revenue This Year
- SPRU $2.12
- INKT N/A
- Revenue Next Year
- SPRU N/A
- INKT N/A
- P/E Ratio
- SPRU N/A
- INKT N/A
- Revenue Growth
- SPRU 9.48
- INKT N/A
- 52 Week Low
- SPRU $1.42
- INKT $4.56
- 52 Week High
- SPRU $3.60
- INKT $13.79
- Technical
- Relative Strength Index (RSI)
- SPRU 33.45
- INKT 51.20
- Support Level
- SPRU $1.50
- INKT $6.80
- Resistance Level
- SPRU $2.23
- INKT $7.55
- Average True Range (ATR)
- SPRU 0.18
- INKT 0.34
- MACD
- SPRU -0.03
- INKT -0.01
- Stochastic Oscillator
- SPRU 25.34
- INKT 36.71
About SPRU Spruce Power Holding Corporation
Spruce Power Holding Corp is an owner and operator of distributed solar energy assets across the United States (the U.S.), offering subscription-based services to home solar assets and customer contracts, making renewable energy more accessible to everyone. The Company's customers are homeowners and the Company's core solar service offerings generate revenues through, the sale of electricity generated by its home solar energy systems to homeowners, third-party contracts to sell solar renewable energy credits (SRECs) generated by the solar energy systems for fixed prices and the servicing of those agreements for other institutional owners of home solar energy systems.
About INKT MiNK Therapeutics Inc.
MiNK Therapeutics Inc is a clinical-stage biopharmaceutical company pioneering the discovery, development, and commercialization of allogeneic invariant natural killer T (iNKT) cell therapies to treat cancer and other immune-mediated diseases. The company is advancing a pipeline of both native and next generation engineered iNKT programs, with a platform designed to facilitate scalable and reproducible manufacturing for off-the-shelf delivery.